oxazoles has been researched along with 2-(2-fluoro-5-methylphenyl)-4,5-dihydro-1h-imidazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bousquet, P; Boutin, J; Bruban, V; Dontenwill, M; Feldman, J; Greney, H; Jarry, C; Payard, M; Pfeiffer, B; Renard, P; Scalbert, E; Schann, S; Vanhoutte, P | 1 |
| Bousquet, P; Bruban, V; Ehrhardt, JD; Estato, V; Feldman, J; Monassier, L; Renard, P; Scalbert, E; Schann, S | 1 |
2 other study(ies) available for oxazoles and 2-(2-fluoro-5-methylphenyl)-4,5-dihydro-1h-imidazole
| Article | Year |
|---|---|
Respective contributions of alpha-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cattle; Cisterna Magna; Cyclic AMP; Guanosine 5'-O-(3-Thiotriphosphate); Hemodynamics; HT29 Cells; Humans; Imidazoles; In Vitro Techniques; Injections; Male; Oxazoles; Rabbits; Radioligand Assay; Receptors, Adrenergic, alpha | 2001 |
Evidence for synergy between alpha(2)-adrenergic and nonadrenergic mechanisms in central blood pressure regulation.
Topics: Adrenergic Agonists; Adrenergic alpha-Agonists; Animals; Antihypertensive Agents; Blood Pressure; Brain Stem; Cardiovascular System; Cyclopropanes; Drug Synergism; Guanosine 5'-O-(3-Thiotriphosphate); Hypotension; Imidazoles; Injections, Intraventricular; Mice; Mice, Transgenic; Microinjections; Nordefrin; Oxazoles; Pyrroles; Rabbits; Receptors, Adrenergic; Receptors, Adrenergic, alpha-2; Rilmenidine; Sympathetic Nervous System | 2002 |